TFF Group (TFFP)

Dec 13, 2024 - TFFP was delisted (reason: winding down operations)

0.0650

-0.0977 (-60.05%)

Inactive · Last trade price on Dec 12, 2024

TFF Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 12, 2024	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Capitalization	480	514	990	988	676	762
Market Cap Growth	-28.13%	-48.07%	0.17%	46.12%	-11.19%	14.67%
Enterprise Value	885	891	1,281	1,182	822	970
Last Close Price	27.80	30.12	47.43	45.04	32.77	31.56

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 12, 2024	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
PE Ratio	13.78	14.76	16.40	16.95	17.90	31.59
PS Ratio	0.99	1.07	1.90	2.04	2.12	2.43
PB Ratio	0.82	0.87	1.81	1.94	1.51	1.69
P/TBV Ratio	1.15	1.23	2.46	2.65	2.13	2.28
P/FCF Ratio	-	-	-	-	35.70	15.67
P/OCF Ratio	42.73	45.77	261.65	-	21.44	13.11

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 12, 2024	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
EV/Sales Ratio	1.77	1.85	2.46	2.44	2.58	3.09
EV/EBITDA Ratio	9.45	9.91	11.17	11.51	15.41	16.44
EV/EBIT Ratio	12.35	12.99	13.06	13.53	20.35	21.90
EV/FCF Ratio	-44.49	-	-	-	43.41	19.96

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 12, 2024	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Debt / Equity Ratio	0.76	0.76	0.70	0.62	0.55	0.62
Debt / EBITDA Ratio	4.97	4.97	3.35	3.08	4.63	4.74
Debt / FCF Ratio	-	-	-	-	13.04	5.76
Asset Turnover	0.43	0.43	0.54	0.56	0.43	0.39
Inventory Turnover	0.55	0.55	0.73	0.84	0.70	0.59
Quick Ratio	0.60	0.60	0.64	0.67	0.84	0.81
Current Ratio	2.06	2.06	1.90	1.74	2.11	2.15
Return on Equity (ROE)	6.18%	6.18%	12.00%	12.23%	9.15%	5.55%
Return on Assets (ROA)	3.85%	3.85%	6.33%	6.27%	3.44%	3.47%
Return on Invested Capital (ROIC)	4.24%	4.24%	7.08%	7.02%	3.78%	3.77%
Return on Capital Employed (ROCE)	8.80%	8.80%	14.40%	15.20%	7.40%	7.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 12, 2024	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Earnings Yield	7.26%	6.78%	6.10%	5.90%	5.59%	3.17%
FCF Yield	-4.14%	-3.87%	-6.02%	-3.26%	2.80%	6.38%
Dividend Yield	923.08%	1.88%	1.35%	0.98%	1.29%	1.33%
Payout Ratio	42.36%	42.36%	23.51%	16.75%	21.29%	38.02%
Buyback Yield / Dilution	0.03%	0.03%	0.00%	-0.01%	0.01%	-0.03%
Total Shareholder Return	923.11%	1.91%	1.35%	0.97%	1.30%	1.31%

SEC Filings: 10-K · 10-Q